U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07088328) titled 'Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial' on July 19.

Brief Summary: The aim of this study is to determine the value of Pentoxifylline for nephroprotection in these neonates with perinatal asphyxia, using cystatin C, regional oxygenation measured near infrared spectroscopy and renal Doppler sonography.

Study Start Date: July 30

Study Type: INTERVENTIONAL

Condition: Hypoxic-Ischemic Encephalopathy Neonatal Encephalopathy Pentoxifylline Adverse Reaction

Intervention: DRUG: Pentoxifylline

Intravenous administration for 3 days

OTHER: placebo distilled water

Intravenous administration for 3 days...